Últimas noticias sobre Procter & Gamble (NYSE:PG) Bolsa

PROCTER & GAMBLE CO/THE

Procter & Gamble

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

IBKR

NFLX

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este miércoles: ABT, NFLX, PG, IBKR y JNJ.

5 acciones en el foco este miércoles: ABT, NFLX, PG, IBKR y JNJ

Dividends

AMGN

AMZN

CSCO

SPDR Dow Jones Industrial Average ETF Trust

NVDA

Descubre las acciones del Dow Jones con los rendimientos por dividendos más altos para 2025. Conoce estrategias populares.

Acciones con mayores dividendos del Dow Jones: Las mejores opciones para 2025

Procter & Gamble Company (The) Common Stock

Procter & Gamble Co

PROSTATYPE GENOMICS AB by Prostatype Genomics AB

PGI Inc

Global X Funds Global X MSCI Portugal ETF

Petrogress Inc

PPB Group Bhd

Peapack-Gladstone Financial Corporation - Common Stock

Peapack Gladstone Financial Corp

PUREGOLD PRICE CLUB INC by Puregold Price Club Inc.

Puregold Price Club Inc

PTT Global Chemical PCL Units Non-Voting Depository Receipts

PTT Global Chemical PCL

PROSEGUR CIA DE SECURIDAD by Prosegur Cia De Securidad SA

Prosegur Compania De Seguridad SA

PGD ECO SOLUTIONS INC by PGD ECO SOLUTIONS INC.

PGD Eco Solutions Inc

PGS ASA

Precigen Inc

Pigeon Corp

STILLWATER CRITICAL MNRLS by STILLWATER CRITICAL MINERALS CORP.

Stillwater Critical Minerals Corp

Invesco Financial Preferred ETF

PIONEER GREEN FARMS INC by PIONEER GREEN FARMS INC.

Pioneer Green Farms Inc

PINGIFY INTERNATIONAL INC by Pingify International Inc.

Pingify International Inc

PIAGGIO & C SPA UNSP/ADR by Piaggio & C Spa Pontedera

Piaggio & C. SpA

PEGASUS GAMING CORP by Pegasus Gaming Corp.

Primega Group Holdings Limited - Ordinary Shares

Primega Group Holdings Ltd

Invesco Global ex-US High Yield Corporate Bond ETF

PEREGRINE INDUS INC by Peregrine Industries, Inc.

Peregrine Industries Inc

PGI Energy Inc

PRESTIGE INTL INC (JAPAN) by Prestige International Inc.

Prestige International Inc

Invesco Golden Dragon China ETF

P2 Gold Inc

PRIMEGEN ENERGY CORP by Primegen Energy Corp.

Primegen Energy Corp

PARAGON FINCL SLTNS INC by Paragon Financial Solutions, Inc. (TN)

Paragon Financial Solutions Inc

Pan Global Resources Inc

PARAGON TECHS INC by Paragon Technologies, Inc.

Paragon Technologies Inc

Progyny Inc

Hartshead Resources NL

PERF-GO-GREEN HLDGS INC by PERF Go-Green Holdings, Inc.

PERF Go-Green Holdings Inc

Patriot Gold Corp

Pimco Global StocksPlus & Income Fund Common Shares of Beneficial Interest

PIMCO Global Stocksplus & Income Fund

PUBLICIS GROUPE ACT by Publicis Groupe S.A.

Publicis Groupe SA

Power Group Projects Corp

POWER GROUP PROJECTS CORP by Power Group Projects Corp.

PARTNERS GRP HLDG ZUG by Partners Group Holding Zug Namen-Akt

Partners Group Holding AG

PGE POLSKA ENERG UNSP/ADR by PGE Polska Energetyczna SA

Polska Grupa Energetyczna SA

PILGRIM PETROLEUM CORP by Pilgrim Petroleum Corp.

Pilgrim Petroleum Corp

First Lithium Minerals Corp

Progressive Corporation (The) Common Stock

Progressive Corp

Paramount Group Inc

Putnam Focused Large Cap Growth ETF

PROPERTYGURU GROUP LTD ORD SHS

PROGRESSIVE GREEN SOL INC by Progressive Green Solutions, Inc.

PEGASUS DIGITAL MOBILITY ACQUISITION CORP CL A ORD SHS

PERTAMINA GEOTHERMAL ENGY by PERTAMINA GEOTHERMAL ENERGY TBK

PGT INC COM

PACIFIC GREEN TECHS by Pacific Green Technologies Inc.

Pacific Green Technologies Inc

Pegatron Corp

Prosegur Cash SA

KK PASONA GROUP INC by KK Pasona Group Inc.

Pasona Group Inc

PROMITHIAN GLBL VNTR INC by Promithian Global Ventures, Inc.

Promithian Global Ventures Inc

PGG Wrightson Ltd

Invesco Preferred ETF

Prosper Gold Corp

PELANGIO EXPLORATION by Pelangio Exploration Inc.

Pelangio Exploration Inc

Pagaya Technologies Ltd. - Class A Ordinary Shares

Pagaya Technologies Ltd

PATRIOT ENERGY CORP DE by Patriot Energy Corp.

Patriot Energy Corp

Principal Real Estate Income Fund Common Shares of Beneficial Interest

Principal Real Estate Income Fund

PAN GLOBAL RESOURCE INC by Pan Global Resource, Inc.

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>B of A Securities cut <strong>Apple Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) price target from $265 to $250. B of A Securities analyst Wamsi Mohan maintained a Buy rating. Apple shares closed at $223.89 on Wednesday. See how other analysts <a href="https://www.benzinga.com/quote/AAPL/analyst-ratings">view this stock</a>.</li>
<li>Truist Securities raised the price target for <strong>The Procter &amp; Gamble Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from $180 to $185. Truist Securities analyst Bill Chappell maintained a Buy rating. Procter &amp; Gamble shares closed at $169.50 on Wednesday. <a href="https://www.benzinga.com/quote/PG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut <strong>M&amp;T Bank Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) price target from $212.5 to $186.5. JP Morgan analyst Andrew Dietrich maintained a Neutral rating. M&amp;T Bank shares closed at $179.71 on Wednesday. See how other analysts <a href="https://www.benzinga.com/quote/MTB/analyst-ratings">view this stock</a>.</li>
<li>Morgan Stanley cut the price target for <strong>RH </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) from $530 to $300. Morgan Stanley analyst Simeon Gutman maintained an Overweight rating. RH shares closed at $249.35 on Wednesday. <a href="https://www.benzinga.com/quote/RH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keefe, Bruyette &amp; Woods cut the price target for <strong>nCino, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) from $40 to $28. Keefe, Bruyette &amp; Woods analyst Ryan Tomasello maintained an Outperform rating. nCino shares closed at $22.59 on Wednesday. <a href="https://www.benzinga.com/quote/NCNO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Evercore ISI Group cut <strong>Sensata Technologies Holding plc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) price target from $40 to $27. Evercore ISI Group analyst Amit Daryanani downgraded the stock from Outperform to In-Line. Sensata Technologies shares settled at $24.61 on Wednesday. <a href="https://www.benzinga.com/quote/ST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies cut <strong>Enphase Energy, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) price target from $54 to $44. Jefferies analyst Sean Milligan maintained an Underperform rating. Enphase Energy shares closed at $62.52 on Wednesday. <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity raised <strong>Sportradar Group AG</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) price target from $30 to $32. Canaccord Genuity analyst Michael Graham maintained a Buy rating. Sportradar shares closed at $22.20 on Wednesday.  <a href="https://www.benzinga.com/quote/SRAD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird slashed the price target for <strong>Fluor Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) from $46 to $43. Baird analyst Andrew Wittmann maintained a Neutral rating. Fluor shares settled at $37.22 on Wednesday. <a href="https://www.benzinga.com/quote/FLR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham cut <strong>Sarepta Therapeutics, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) price target from $202 to $183. Needham analyst Gil Blum maintained a Buy rating. Sarepta Therapeutics shares closed at $62.47 on Wednesday. <a href="https://www.benzinga.com/quote/SRPT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p>Considering buying AAPL stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03091101/image-37-1024x590.png" alt="" class="wp-image-855474" style="width:516px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03091101/image-37-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03091101/image-37-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03091101/image-37-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03091101/image-37.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/25/04/44622367/acuity-rh-and-3-stocks-to-watch-heading-into-thursday">Acuity, RH And 3 Stocks To Watch Heading Into Thursday</a></strong> </li>
</ul>
<p><em>Photo via Shutterstock</em></p>


Price Target

Analyst Ratings

AAPL

ENPH

NCNO

SRAD

SRPT

Apple To $250? Here Are 10 Top Analyst Forecasts For Thursday

<p>Truist Securities  analyst Bill Chappell   maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Buy and raises the price target from $180 to $185.</p>


Truist Securities Maintains Buy on Procter & Gamble, Raises Price Target to $185

<p>If you&#8217;ve been paying attention to the stock market recently, you must have come across a rather unexpected turn of events—value stocks are taking center stage from their flashy growth rivals. Over the course of three months, the Russell 1000 Value Index has <a href="https://www.benzinga.com/general/market-summary/25/03/44555763/value-stocks-are-crushing-growth-superstars-in-2025-is-more-to-come">beaten the Russell 1000 Growth Index </a>by a healthy 11%. That&#8217;s a far cry from this time last year, when tech and AI plays were driving the market upwards.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/03/44569468/growth-or-value-allsprings-new-etfs-offer-both">Growth Or Value? Allspring&#8217;s New ETFs Offer Both</a></strong></p>
<p>With tariffs, geopolitical tensions, and recession jitters swirling, investors are flocking to the relative safety of value stocks. But is it a permanent pivot, or a temporary sidetrack? Although no one knows for sure what the market will do, history suggests that value stocks have a way of surviving rough patches.</p>
<p>For those looking to ride the wave, these <a href="https://www.benzinga.com/etfs">four value-based ETFs</a> are worth considering:</p>
<p><strong>iShares Russell 1000 Value ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWD#NYSE">IWD</a>)</p>
<p>The first choice for most investors seeking to follow the Russell 1000 Value Index, IWD offers broad exposure to large-cap value stocks from a wide range of sectors, such as financials, healthcare, and consumer staples. Some of its holdings include stocks of<strong> JP Morgan Chase &amp; Co</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), <strong>Exxon Mobil Corp. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) and <strong>Procter &amp; Gamble Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>). With its size and liquidity, this ETF is a convenient means of achieving diversified exposure to the value sector. It carries an expense ratio of 0.19%.</p>
<p><strong>Vanguard Value ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTV#NYSE">VTV</a>)</p>
<p>An affordable fund with a bottom-of-the-barrel expense ratio of 0.04%, VTV tracks the CRSP US Large Cap Value Index. Blue-chip stalwarts such as  JPMorgan Chase, and <strong>Johnson &amp; Johnson</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) are overweights in this fund, which is a good bet for stability and long-term growth.</p>
<p><strong>SPDR S&amp;P 500 Value ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPYV#NYSE">SPYV</a>)</p>
<p>If you desire exposure to value stocks as part of the larger S&amp;P 500, SPYV may be considered. This ETF targets S&amp;P 500 stocks that reflect strong value features in terms of low price-to-earnings and price-to-book ratios. With the valuation differential between value and growth stocks as high as it is now, this ETF is poised to profit from a possible market correction. The portfolio is similar to that of IWD and VTV, and the expense ratio is 0.04%.</p>
<p><strong>Schwab U.S. Dividend Equity ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>)</p>
<p>Dividend stocks tend to overlap with value stocks, and SCHD is a good representative of this case. Concentrating on high-grade dividend-paying businesses, this ETF not only gets investors exposed to value stocks but also provides a steady income under market uncertainty. Its portfolio carries blue-chip brands such as <strong>Coca-Cola</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), <strong>PepsiCo </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>), and <strong>Pfizer</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>). This ETF comes with an expense ratio of 0.06%.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/25/03/44570070/tariffs-inflation-and-tumbling-markets-these-5-etfs-thrived-amid-the-chaos-last-week">Tariffs, Inflation And Tumbling Markets: These 5 ETFs Thrived Amid Last Week&#8217;s Chaos</a></strong></p>
<p><strong>Why Value Could Stay On Top</strong></p>
<p>Last quarter&#8217;s value outperformance is more than just jitters in the market. It&#8217;s because, as BlackRock&#8217;s Global CIO of Fundamental Equities <strong>Tony DeSpirito </strong><a href="https://www.blackrock.com/us/individual/insights/value-stocks-underweight-and-unaware?utm_source=chatgpt.com">says</a>, growth stocks now comprise almost 40% of the S&amp;P 500—more than double their long-term average of 24%. With the valuations pulled forward, investors might begin shifting into value stocks for diversification. In addition, sectors like utilities, health care, and materials—staples in value indexes—are less tariff-vulnerable and potentially even positively affected by changes in trade policy.</p>
<p>While growth stocks may recover over time, the current market environment has favored value stocks. For those interested in exploring this trend, these four ETFs offer examples of funds that focus on value investing.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/new-etfs/25/03/44570028/westwoods-new-bfre-etf-prioritizes-democracy-over-autocracy">Westwood&#8217;s New BFRE ETF Prioritizes Democracy Over Autocracy</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Specialty ETFs

ETFs

SCHD

SPYV

Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend

WIIM

DLTR

Shares of consumer staples stocks are trading higher as tariffs uncertainty may be driving a shift towards defensive stocks.

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Procter &amp; Gamble</strong>.</p>
<p>Looking at options history for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) we detected 11 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 18% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $575,874 and 8, calls, for a total amount of $667,168.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $210.0 for Procter &amp; Gamble, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale trades within a strike price range from $100.0 to $210.0 in the last 30 days. </p>
<h3>Procter &amp; Gamble Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743447665_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.9</td>
<td>$2.79</td>
<td>$2.89</td>
<td>$165.00</td>
<td>$299.3K</td>
<td>2.3K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.7</td>
<td>$1.61</td>
<td>$1.63</td>
<td>$160.00</td>
<td>$168.2K</td>
<td>6.1K</td>
<td>1.1K</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$8.0</td>
<td>$7.75</td>
<td>$7.9</td>
<td>$165.00</td>
<td>$158.0K</td>
<td>1.4K</td>
<td>419</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$7.9</td>
<td>$7.75</td>
<td>$7.9</td>
<td>$165.00</td>
<td>$158.0K</td>
<td>1.4K</td>
<td>219</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/18/26</td>
<td>$6.65</td>
<td>$5.15</td>
<td>$5.95</td>
<td>$150.00</td>
<td>$108.2K</td>
<td>381</td>
<td>182</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<p>In light of the recent options history for Procter &amp; Gamble, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Procter &amp; Gamble's Current Market Status</h3>
<ul>
<li>With a volume of 4,912,357, the price of PG is up 1.17% at $170.0. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 24 days.</li>
</ul>
<h3>Professional Analyst Ratings for Procter &amp; Gamble</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $165.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Procter &amp; Gamble, maintaining a target price of $165. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Procter &amp; Gamble, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Procter & Gamble Options Trading: A Deep Dive into Market Sentiment

<p>This year&#8217;s <a href="https://www.benzinga.com/topic/tariffs">tariff storms</a> have hit tech stocks, semiconductor stocks and even metal and mining stocks. Now, they&#8217;re starting to hit dividend stocks, too.</p>
<p>Ford CEO <strong><a href="https://www.benzinga.com/topic/jim-farley">Jim Farley</a> </strong>recently stated, &#8220;If tariffs persist, it will mean billions of dollars of losses for the domestic car industry.&#8221;</p>
<p>That&#8217;s a problem for investors counting on Ford&#8217;s usual robust dividend yield, currently at 6.10%. That figure could easily fall as the auto manufacturer&#8217;s profitability guidance points to lower net income levels as tariffs hit the company&#8217;s investments in manufacturing in Canada and Mexico.</p>
<p>It&#8217;s not just about Ford, either. Other major American brands face lower dividend payouts, too, mostly due to affordability.</p>
<p>But three big-name dividend stocks look set to weather the tariff storm.</p>
<h2 class="wp-block-heading"><strong>A Souring Dividend Climate </strong></h2>
<p>In 2024, Ford&#8217;s high dividend was supported by $5.9 billion in net income and $6.7 billion in free cash flow. The company projects the free cash flow figure will decline to between $3.5 billion and $4.5 billion in 2025, as the company figures to pay more to ship products into the US in a post-tariff shift business environment.</p>
<p>Consequently, analysts expect Ford to curb its dividend payout to approximately .12 cents per share, with more doubts sown daily, and the 25% tariffs remain in place.</p>
<p>Some market experts say companies like Ford, which may cut dividend payouts, can&#8217;t solely blame tariffs.</p>
<p>&#8220;Although the general impact of any additional fiscal burdening, including not only tariffs but, let&#8217;s say, tax increases, on stock dividends, is unequivocally negative, we should be able to separate apples from oranges here,&#8221; said <strong>John Murillo</strong>, chief dealing officer of B2BROKER, a global fintech solutions provider for financial institutions:</p>
<p>In Murillo&#8217;s view, Ford&#8217;s claim that their intention to cut dividends would be linked to the tariff situation appears unjustified. &#8220;In fact, Ford Motor Company is a gross and net beneficiary of Trump&#8217;s imposition of tariffs on European automobile imports.&#8221;</p>
<p>Ford isn&#8217;t the only company affected. &#8220;The tariff/dividend issue is significant,&#8221; said <strong>David Capablanca</strong>, a veteran securities trader and host of the Friendly Bear Podcast. &#8220;When tariffs are introduced, consumer spending typically decreases, which affects the entire economy and, by extension, the stock market.&#8221;</p>
<p>As a result, stock prices generally go down, and dividend payouts are often reduced. &#8220;This is just the nature of things,&#8221; Capablanca said. &#8220;Companies adjust their dividends based on how the company is performing, and when the market is in a downturn, dividends will reflect that.&#8221;</p>
<h2 class="wp-block-heading"><strong>Three Good Dividend Stocks In Tough Tariff Times</strong></h2>
<p>Capablanca advises income-minded investors to focus on stocks with good overall performance, not just those offering a high dividend.</p>
<p>&#8220;Look at the stock&#8217;s chart and see if it looks bullish,&#8221; he said. &#8220;Make sure it&#8217;s trending upward or at least holding steady. If you believe in the company and its sector, it&#8217;s important to ensure the stock isn&#8217;t in a downward spiral.&#8221;</p>
<p>Many struggling companies will try to entice investors with high dividends. &#8220;In those cases, the stock&#8217;s performance is what&#8217;s important,&#8221; he added.</p>
<p>Here are three dividend-paying stocks that fit the bill.</p>
<h2 class="wp-block-heading"><strong>UPS</strong></h2>
<p><strong>UPS </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) is a sold dividend stock on<strong> </strong>Capablanca&#8217;s radar screen right now, and the delivery giant is continuing to back its shareholder payouts. In a January analyst call, company CEO Carole Tome noted, &#8220;From a dividend payout perspective, we&#8217;re targeting 50% of earnings, and we&#8217;re higher than that… So (we have) plenty of liquidity to pay the dividend.&#8221;</p>
<p>Despite recently losing about 50% of its Amazon delivery business, UPS says it has $5.7 billion in free cash flow, plans to pay $5.5 billion in dividends and will rebuy $1 billion of stock. The stock is down 12.50% this year, far outpacing the market and presenting a buying opportunity, especially when considering the current 5.94% dividend yield.</p>
<h2 class="wp-block-heading"><strong>PepsiCo</strong></h2>
<p><strong>PepsiCo </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) is one of the bigger US companies that appears to be immune to the Trump tariffs, taking on fewer trading risks than its competitors, having relatively fewer products on tariff lists and being another company that values its shareholders with regularly substantial dividend payouts.</p>
<p>&#8220;This is a worldwide consumer staple with pricing power and a 50-plus year dividend history that is resilient even in markets filled with tariffs,&#8221; said <strong>Fei Chen</strong>, CEO of Intellectia AI and a long-time market investment strategist. The stock is down a bit this year, at -1.14%, but much less than the market&#8217;s 5% drop. It also boasts a 3.61% dividend yield.</p>
<h2 class="wp-block-heading"><strong>Proctor &amp; Gamble</strong></h2>
<p>A traditional inflation-passer with worldwide brand power, <strong>Proctor &amp; Gamble </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) historically absorbs price increases while continuing to make steady payouts. &#8220;Firms like Proctor &amp; Gamble score well on pricing power and capital efficiency, the two pillars of dividend safety in volatile times,&#8221; Chen notes. It&#8217;s almost flat for the year, with a -0.30% return and a 2.40% dividend yield.</p>
<h2 class="wp-block-heading"><strong>Don&#8217;t Make These Dividend Investing Mistakes</strong></h2>
<p>The most typical mistake investors make when buying high-dividend stocks is failing to diversify across sectors.</p>
<p>&#8220;Many investors prioritize the dividends&#8217; percentage value and payout history while playing down the essence of the companies&#8217; operations,&#8221; Murillo said. &#8220;The current turmoil beating some dividend stocks ostensibly linked to impairments caused by the U.S. import tariffs brings this omission to the forefront.&#8221;</p>
<p>Capablanca warns that income-minded investors should also be cautious and not buy stocks solely based on high dividend yields.</p>
<p>&#8220;Some companies that aren&#8217;t performing well may try to attract investors by offering high dividends, but this can be a dangerous strategy,&#8221; he said. &#8220;If the stock price is consistently falling, the dividend won&#8217;t compensate for the loss in stock value.&#8221;</p>
<p>For example, if you buy a $100 stock that offers a decent dividend but the price drops to $90, $80, or even $60, the dividend becomes insignificant because you&#8217;re losing money on the overall investment,&#8221; he said. &#8220;The key is to look for stocks with decent dividends and a healthy trajectory.&#8221;</p>
<h2 class="wp-block-heading"><strong>Earnings Season Alert: Are You Ready for Volatility?</strong></h2>
<p>Earnings season brings major market moves—are you prepared to take advantage of them? <strong>Matt Maley</strong>, a former institutional trader with over 35 years of experience, is hosting a live session on Wednesday, April 2, at 6 PM ET to show you how to trade the volatility and make the most of Q1 earnings season. He'll share his exact approach for spotting big opportunities, managing risk, and avoiding the costly mistakes that most traders make. Markets move fast—<strong><a href="https://events2.benzinga.com/matt-maley-webinar-wed-apr2-2025-registration">reserve your seat today</a></strong> and get prepared for the action.</p>
<p><em>Photo: Shutterstock</em></p>


Opinion

Tech

3 Dividend Giants To Buy As Tariffs Hit Stocks

<p>In the latest quarter, 12 analysts provided ratings for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $173.0, a high estimate of $209.00, and a low estimate of $155.00. A decline of 1.1% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743112845_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The standing of Procter &amp; Gamble among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$165.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$172.00</td>
<td>$173.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$165.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$159.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$209.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$155.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$161.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$189.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$181.00</td>
<td>$186.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$176.00</td>
<td>$190.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Procter &amp; Gamble. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Procter &amp; Gamble compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Procter &amp; Gamble's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Procter &amp; Gamble's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Procter &amp; Gamble analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Procter &amp; Gamble</h2>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<h3>Procter &amp; Gamble: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Procter &amp; Gamble showcased positive performance, achieving a revenue growth rate of <strong>2.06%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> Procter &amp; Gamble's net margin excels beyond industry benchmarks, reaching <strong>20.83%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Procter &amp; Gamble's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>8.99%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Procter &amp; Gamble's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>3.66%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Procter &amp; Gamble's debt-to-equity ratio is below the industry average. With a ratio of <b>0.69</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Beyond The Numbers: 12 Analysts Discuss Procter & Gamble Stock

<p>Deep-pocketed investors have adopted a bearish approach towards Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PG usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Procter &amp; Gamble. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 22% leaning bullish and 77% bearish. Among these notable options, 4 are puts, totaling $264,885, and 5 are calls, amounting to $708,322.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $155.0 to $190.0 for Procter &amp; Gamble during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale trades within a strike price range from $155.0 to $190.0 in the last 30 days. </p>
<h3>Procter &amp; Gamble Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1743108443_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$21.95</td>
<td>$21.1</td>
<td>$21.32</td>
<td>$155.00</td>
<td>$533.0K</td>
<td>315</td>
<td align="right">250</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.6</td>
<td>$3.3</td>
<td>$3.5</td>
<td>$165.00</td>
<td>$94.8K</td>
<td>1.7K</td>
<td align="right">272</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$12.35</td>
<td>$11.0</td>
<td>$11.45</td>
<td>$170.00</td>
<td>$91.6K</td>
<td>29</td>
<td align="right">80</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.6</td>
<td>$3.45</td>
<td>$3.51</td>
<td>$190.00</td>
<td>$67.3K</td>
<td>2.5K</td>
<td align="right">216</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$6.35</td>
<td>$6.3</td>
<td>$6.3</td>
<td>$162.50</td>
<td>$47.2K</td>
<td>242</td>
<td align="right">81</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<p>Having examined the options trading patterns of Procter &amp; Gamble, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Procter &amp; Gamble Standing Right Now?</h3>
<ul>
<li>With a trading volume of 6,172,580, the price of PG is up by 1.39%, reaching $168.9.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 28 days from now.</li>
</ul>
<h3>Expert Opinions on Procter &amp; Gamble</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $165.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Procter &amp; Gamble with a target price of $165. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter &amp; Gamble options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


<p>Barclays  analyst Lauren Lieberman   maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Equal-Weight and raises the price target from $159 to $165.</p>


Barclays Maintains Equal-Weight on Procter & Gamble, Raises Price Target to $165

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Procter &amp; Gamble</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PG, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Procter &amp; Gamble.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 66% bullish and 33%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $270,581, and 4 are calls, for a total amount of $160,940.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $155.0 to $190.0 for Procter &amp; Gamble over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Procter &amp; Gamble stands at 798.2, with a total volume reaching 1,211.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Procter &amp; Gamble, situated within the strike price corridor from $155.0 to $190.0, throughout the last 30 days.</p>
<h3>Procter &amp; Gamble Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1742328024_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$7.95</td>
<td>$7.8</td>
<td>$7.8</td>
<td>$155.00</td>
<td>$159.1K</td>
<td align="right">163</td>
<td align="right">227</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$7.2</td>
<td>$7.15</td>
<td>$7.2</td>
<td>$175.00</td>
<td>$57.6K</td>
<td align="right">614</td>
<td align="right">144</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$7.35</td>
<td>$7.15</td>
<td>$7.2</td>
<td>$175.00</td>
<td>$45.3K</td>
<td align="right">614</td>
<td align="right">1</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$7.85</td>
<td>$7.8</td>
<td>$7.8</td>
<td>$155.00</td>
<td>$30.4K</td>
<td align="right">163</td>
<td align="right">337</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$2.1</td>
<td>$1.96</td>
<td>$2.1</td>
<td>$190.00</td>
<td>$30.2K</td>
<td align="right">804</td>
<td align="right">3</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<h3>Where Is Procter &amp; Gamble Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,224,819, the PG's price is up by 0.18%, now at $170.07. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 34 days.</li>
</ul>
<h3>What The Experts Say On Procter &amp; Gamble</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $172.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Procter &amp; Gamble, maintaining a target price of $172. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Procter &amp; Gamble, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Smart Money Is Betting Big In Procter & Gamble Options

General

CORRECTION: PagerDuty ticker is "PD"

Shares of consumer staples stocks are trading lower. The sector may be down amid a rotation into tech stocks on Wednesday. Investors may also be assessing February CPI data, which showed slowing food inflation.

<p>Investors with significant funds have taken a bearish position in Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), a development that retail traders should be aware of.</p>
<p>This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga. The exact nature of these investors remains a mystery, but such a major move in PG usually indicates foreknowledge of upcoming events.</p>
<p>Today, Benzinga's options scanner identified 11 options transactions for Procter &amp; Gamble. This is an unusual occurrence. The sentiment among these large-scale traders is mixed, with 27% being bullish and 54% bearish. Of all the options we discovered, 10 are puts, valued at $675,018, and there was a single call, worth $27,000.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $170.0 and $175.0 for Procter &amp; Gamble, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Procter &amp; Gamble options trades today is 3842.75 with a total volume of 3,890.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Procter &amp; Gamble's big money trades within a strike price range of $170.0 to $175.0 over the last 30 days.</p>
<h3>Procter &amp; Gamble 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741787167_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$3.9</td>
<td>$3.6</td>
<td>$3.6</td>
<td>$175.00</td>
<td>$180.0K</td>
<td>7.9K</td>
<td>1.9K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$4.5</td>
<td>$4.25</td>
<td>$4.3</td>
<td>$175.00</td>
<td>$129.0K</td>
<td>7.9K</td>
<td>901</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/14/25</td>
<td>$4.5</td>
<td>$4.3</td>
<td>$4.35</td>
<td>$175.00</td>
<td>$80.9K</td>
<td>7.9K</td>
<td>570</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/14/25</td>
<td>$4.4</td>
<td>$4.3</td>
<td>$4.4</td>
<td>$175.00</td>
<td>$80.5K</td>
<td>7.9K</td>
<td>158</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$4.4</td>
<td>$4.2</td>
<td>$4.4</td>
<td>$175.00</td>
<td>$37.4K</td>
<td>7.9K</td>
<td>72</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<p>In light of the recent options history for Procter &amp; Gamble, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Procter &amp; Gamble</h3>
<ul>
<li>Currently trading with a volume of 38,765, the PG's price is down by 0.0%, now at $173.12. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 40 days.</li>
</ul>
<h3>What Analysts Are Saying About Procter &amp; Gamble</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $172.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Procter &amp; Gamble, targeting a price of $172. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Procter &amp; Gamble with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


<p>A March filing shows that Representative Lloyd Doggett reported a purchase in Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), valued between $1,001 and $15,000. The transaction date is listed as March 10, 2025, with the report published on March 10, 2025.</p>
<p>At present, Procter &amp; Gamble shares are trading down 1.72% at $173.23.</p>
<h3>Representative's Recent Trading Activity</h3>
<p>Over the previous three years, Lloyd Doggett conducted 69 trades, totaling more than $69 thousand. The largest of these were in Coca-Cola and Procter &amp; Gamble stock. Some of the most notable transactions the Rep. has executed recently include: </p>
<ul>
<li><strong>Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>):</strong> $1,001 - $15,000 Purchase</li>
<li><strong>Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>):</strong> $1,001 - $15,000 Purchase</li>
</ul>
<p>Here's a summary of Lloyd Doggett's most recent trades:</p>
<table>
<thead>
<tr>
<th><strong>Company</strong></th>
<th><strong>Ticker</strong></th>
<th><strong>Stock Type</strong></th>
<th><strong>Amount</strong></th>
<th><strong>Transaction Type</strong></th>
<th><strong>Transaction Date</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Procter &amp; Gamble</td>
<td>PG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-02-18</td>
</tr>
<tr>
<td>Coca-Cola</td>
<td>KO</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-16</td>
</tr>
<tr>
<td>Home Depot</td>
<td>HD</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-12</td>
</tr>
<tr>
<td>PPG Indus</td>
<td>PPG</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-12</td>
</tr>
</tbody>
</table>
<p>Stay informed on Lloyd Doggett's trades and other members of Congress with our real-time <a href="https://www.benzinga.com/gov-trades/members/lloyd-doggett"><strong>government trades tracking tool</strong></a>!</p>
<h3>Why Congressional Transactions Matter</h3>
<p>A congressional transaction is when any representative or senator either buys or sells an individual stock.</p>
<p>Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.</p>
<p>In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.</p>
<h3>The Importance of Congressional Transactions</h3>
<p>Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.</p>
<p>When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.</p>
<p>A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Government

Politics

Rep. Lloyd Doggett Has Bought Up to $15K Worth Of Procter & Gamble Stock: Here's What You Should Know

<p><img alt="ETF Exchange traded fund Investment finance concept. Abstract background." class="article-image-one" src="https://www.marketbeat.com/logos/articles/med_20250304100712_broaden-your-etf-exposure-with-these-3-overlooked.jpg" style="height:504px; width:1200px" /></p>
<p>Volatility is surging, with the <a href="https://www.marketbeat.com/financial-terms/learning-about-the-vix-volatilty-index/">VIX &quot;fear&quot; index</a> climbing to its highest level so far in 2025 as of March 3. Investors have been spooked by an inverted yield curve in Treasury rates and corresponding concerns about a potential recession, as well as uncertainty surrounding tariffs by the Trump administration, dropping consumer confidence levels, and more. In the midst of these challenges, exchange-traded funds (ETFs) can be a haven and a way to diversify a portfolio to protect against headwinds.</p>
<p>Investors looking to expand their ETF focus in the new year might consider any number of defensive plays that aim to minimize downside risk in a tumultuous market. More adventurous investors might also use this as an opportunity to invest in underappreciated ETFs&mdash;funds that have had a strong showing so far in 2025 but which have relatively modest assets under management of $25 billion or less. These are not the most obscure ETFs available&mdash;to be sure, there are plenty with asset bases just a fraction of that level&mdash;but they are also well behind many of the most popular ETF options investors tend to gravitate toward.</p>
<h2><strong>Strong 2025 Performance and Global Exposure With High Dividends</strong></h2>
<p>The <a href="https://www.marketbeat.com/stocks/BATS/EFV/">iShares MSCI EAFE Value ETF (BATS: </a><a class="ticker" href="https://www.benzinga.com/stock/efv#BATS">EFV</a>) may appeal to investors seeking increased exposure to equities outside of the North American space. Focusing on Europe, Australia, Asia, and the Far East (EAFE), EFV prioritizes companies with value characteristics such as low pricing multiples.</p>
<p>[content-module:CompanyOverview|BATS:EFV]</p>
<p>Value stocks have seen success as a group early in 2025, and EFV bets that these trends will continue, at least outside of the United States and Canada.</p>
<p>A key draw of EFV is its wide reach. The fund&#39;s nearly 450 holdings are tilted toward financials (about 34% of the portfolio as of February 28), but all sectors are represented. Similarly, though Japan, the United Kingdom, and France are the countries best represented in EFV&#39;s basket of stocks, companies from more than a dozen nations are included.</p>
<p>Many of the names in EFV&#39;s portfolio also maintain high dividend yields, and the fund itself has an annual dividend yield of 4.29%, giving investors a key added bonus of regular passive income. As of March 3, EFV has surged by about 11% so far in 2025, while the S&amp;P 500 is down 0.3% over the same period.</p>
<h2><strong>Low-Cost Global Exposure, Solid 2025 Returns</strong></h2>
<p>Investors seeking an ETF similar to EFV above but with a broader basket and a lower expense ratio might consider the <a href="https://www.marketbeat.com/stocks/NYSEARCA/SPDW/">SPDR S&amp;P World ex-US ETF (NYSEARCA: SPDW)</a>.</p>
<p>[content-module:CompanyOverview|NYSEARCA:SPDW]</p>
<p>While EFV&#39;s annual fee will cost investors 0.33%, SPDW&#39;s is a mere 0.03%, making it one of the least expensive ETFs available.</p>
<p>Further, SPDW&#39;s investment mandate is exceptionally wide&mdash;the fund holds a huge portfolio of large-cap developed international equities outside the United States. With extensive exposure to nearly 5,000 stocks, SPDW remains broadly diversified without a distinct geographic or sector focus.</p>
<p>However, it makes an excellent play when global markets are thriving, and the U.S. may be struggling&mdash;or for investors simply looking to rebalance their portfolio away from a common U.S. tilt. SPDW&#39;s strategy is paying off so far this year, with returns of nearly 8% so far as of March 3.</p>
<h2><strong>Modest Assets Don&#39;t Interfere With Stable Holdings, High Dividend Yield</strong></h2>
<p>Unlike the funds above, the <a href="https://www.marketbeat.com/stocks/NYSEARCA/HDV/">iShares Core High Dividend ETF (NYSEARCA: HDV)</a> does focus on U.S. equities&mdash;specifically, on <a href="https://www.marketbeat.com/compare-stocks/dividend-stocks/">dividend-paying</a> large-caps that show signs of being undervalued.</p>
<p>[content-module:CompanyOverview|NYSEARCA:HDV]</p>
<p>The 76 companies in HDV&#39;s portfolio include household names like&nbsp;<a href="https://www.marketbeat.com/stocks/NYSE/JNJ/">Johnson &amp; Johnson (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>) and <a href="https://www.marketbeat.com/stocks/NYSE/PG/">Procter &amp; Gamble Co. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/pg#NYSE">PG</a>).</p>
<p>Companies like these are incredibly well established, likely to continue to see strong business even in the face of challenging external economic conditions, and appealing to investors for their history of dividend payments.</p>
<p>HDV sports a fairly high annual dividend yield of 3.44%. The stable status of the individual stocks making up HDV&#39;s portfolio means the fund has also fared well so far in 2025 despite uncertainty in the market. HDV is up more than 7% year-to-date as of March 3. What&#39;s more, its low expense ratio of 0.08% makes it competitive with many other dividend funds. It&#39;s surprising, then, that HDV has an AUM of just $11 billion, making it the smallest fund on this list based on asset base.</p>
<h2><a href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&amp;RegistrationCode=SyndicatedArticleLink" style="text-decoration:none;color:var(--dark-blue); font-weight:500;">Where Should You Invest $1,000 Right Now?</a></h2>
<p>Before you make your next trade, you&#39;ll want to hear this.</p>
<p>MarketBeat keeps track of Wall Street&#39;s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p>
<p>Our team has identified the <a href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&amp;RegistrationCode=SyndicatedArticleLink">five stocks</a> that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p>
<p>They believe these five stocks are the five best companies for investors to buy now...</p>
<p><a class="btn btn-featured" href="https://www.marketbeat.com/newsletter/PDFoffer.aspx?offer=top5&amp;RegistrationCode=SyndicatedArticleLink" style="text-decoration:none">See The Five Stocks Here </a></p>
<p>The article &quot;<a href="https://www.marketbeat.com/stock-ideas/broaden-your-etf-exposure-with-these-3-overlooked-funds/">Broaden Your ETF Exposure With These 3 Overlooked Funds</a>&quot; first appeared on MarketBeat.</p>


Broaden Your ETF Exposure With These 3 Overlooked Funds

<p>Financial giants have made a conspicuous bullish move on Procter &amp; Gamble. Our analysis of options history for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) revealed 16 unusual trades.</p>
<p>Delving into the details, we found 43% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $89,692, and 13 were calls, valued at $854,808.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $200.0 for Procter &amp; Gamble over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Procter &amp; Gamble options trades today is 1864.54 with a total volume of 6,341.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Procter &amp; Gamble's big money trades within a strike price range of $150.0 to $200.0 over the last 30 days.</p>
<h3>Procter &amp; Gamble Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741118463_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.7</td>
<td>$12.55</td>
<td>$13.29</td>
<td>$180.00</td>
<td>$159.4K</td>
<td>5.1K</td>
<td>202</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.64</td>
<td>$2.43</td>
<td>$2.45</td>
<td>$195.00</td>
<td>$113.6K</td>
<td>192</td>
<td>470</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$0.79</td>
<td>$0.68</td>
<td>$0.79</td>
<td>$185.00</td>
<td>$109.7K</td>
<td>2.5K</td>
<td>1.4K</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$9.75</td>
<td>$9.35</td>
<td>$9.75</td>
<td>$185.00</td>
<td>$102.3K</td>
<td>2.3K</td>
<td>148</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.7</td>
<td>$10.6</td>
<td>$10.6</td>
<td>$170.00</td>
<td>$63.6K</td>
<td>1.4K</td>
<td>85</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<p>Following our analysis of the options activities associated with Procter &amp; Gamble, we pivot to a closer look at the company's own performance.</p>
<h3>Procter &amp; Gamble's Current Market Status</h3>
<ul>
<li>Trading volume stands at 8,122,877, with PG's price down by -0.25%, positioned at $175.15.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 48 days.</li>
</ul>
<h3>What The Experts Say On Procter &amp; Gamble</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $172.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Procter &amp; Gamble, targeting a price of $172. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter &amp; Gamble options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Market Whales and Their Recent Bets on Procter & Gamble Options

<p>U.S. markets suffered a steep selloff Monday as President <strong>Donald Trump</strong> announced sweeping new tariffs, extending last week&#8217;s losses and driving declines <a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying">across all major sectors</a>.</p>
<p><strong>What Happened</strong>: The S&amp;P 500 tracked by <strong>The SPDR S&amp;P 500 </strong>(NYSE:&nbsp;SPY) closed at 5,849.72, sinking 1.76%, continuing its retreat from 5,983 on Feb 24. The Nasdaq-100 monitored by <strong>Invesco QQQ Trust, Series 1</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell to 20,425.58, down from 21,352 a week earlier, marking a significant correction from recent highs.</p>
<p>Technology stocks bore the brunt of the selloff, with <strong>NVIDIA Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) plummeting 8.63% and <strong>ARM Holdings </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) dropping 8.05%. The sector&#8217;s decline follows a brutal week where <strong>AppLovin</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) had already lost 20.64% and <strong>Super Micro Computer</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) fell 19.67% between Feb. 24-28, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.</p>
<p>However, some stocks showed positive performance amid the broader market selloff, according to the Benzinga Stock Heat Map. </p>
<p>In chemicals and allied products, <strong>Eli Lilly &amp; Co.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) gained 0.83%, while <strong>Procter &amp; Gamble Co.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and <strong>Johnson &amp; Johnson</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) also edged higher. <strong>Philip Morris International Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) rose 2.33% in the tobacco sector. In telecom, <strong>T-Mobile US Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) and <strong>Verizon Communications Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) climbed over 1.5%. Transport by air saw <strong>PHI Group Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIG#NASDAQ">PHIG</a>) gain 2.3%. Meanwhile, <strong>Coca-Cola Co.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) and <strong>PepsiCo Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) both advanced over 1.3%.</p>
<p><figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/04011143/Screenshot-2025-03-04-at-11.40.56%E2%80%AFAM-1024x590.png" alt="" class="wp-image-807304" /></figure></p>
<p>Industrials saw significant pressure, with <strong>Vertiv Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) falling 10.09% and <strong>FTAI Aviation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) down 7.89%. In healthcare, <strong>BeOne Medicines </strong>dropped 10.10% while <strong>Hims &amp; Hers Health </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) declined 9.77%.</p>
<p>Financial stocks weren&#8217;t spared, with <strong>Robinhood Markets </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) shedding 6.51% and <strong>SoFi Technologies </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) losing 6.40%. The slide continued a trend from last week when <strong>PayPal Holdings </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) had already declined 5.58%.</p>
<p>Consumer discretionary and staples both tumbled, with <strong>Li Auto</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) plunging 10.96% and <strong>Dollar Tree </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) falling 6.02%. Energy stocks like <strong>Ovintiv</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) dropped 8.65%, while utilities <strong>Vistra</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) and <strong>Constellation Energy</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) both fell 7.40%.</p>
<p><strong>See Also:&nbsp;<a href="https://www.benzinga.com/personal-finance/25/03/44068159/nba-legend-shaq-says-his-net-worth-quadrupled-once-he-took-note-from-jeff-bezos-and-started-investing-in-things-that-change-peoples-lives" target="_blank" rel="noreferrer noopener">NBA Legend Shaq Says His Net Worth ‘Quadrupled&#8217; Once He Took Note From Jeff Bezos And Started Investing In Things That ‘Change People&#8217;s Lives&#8217;</a></strong></p>
<p><strong>Why It Matter</strong>s: The catalyst for Monday&#8217;s selloff was Trump&#8217;s announcement of 25% tariffs on imports from Canada and Mexico, plus an additional 20% tariff on Chinese goods. The Kobeissi Letter noted these increases would raise the U.S. average effective tariff to approximately 20%, levels not seen <a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying">since the Great Depression</a>.</p>
<p>Market strategist <strong>Tom Lee</strong> of <strong>Fundstrat</strong> suggested this week could mark the bottom for stocks in the <a href="https://www.benzinga.com/markets/equities/25/03/44072005/tom-lee-sees-stocks-potentially-hitting-first-half-lows-this-week-bad-news-has-gotten-priced-in">first half of 2025</a>, noting &#8220;a lot of bad news has gotten priced in&#8221; and that retail sentiment has reached bearish levels comparable to fall 2022.</p>
<p>Wall Street remains divided on the tariffs&#8217; impact, with <strong>Peter Schiff </strong>warning of domestic economic harm while others like <strong>Anthony Pompliano</strong> pointed to <strong>Taiwan Semiconductor</strong>&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) $100 billion U.S. investment announcement as evidence tariffs might boost <a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying">domestic manufacturing</a>.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/personal-finance/25/03/44065932/mark-cuban-was-asked-how-hed-invest-100k-his-answer-buy-bulk-toothpaste-and-soup-for-the-best-guaranteed-return-on-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Was Asked How He&#8217;d Invest $100K — His Answer? Buy Bulk Toothpaste And Soup For The ‘Best Guaranteed Return On Investment&#8217;</a></strong></li>
</ul>
<p><em>Image Via Shutterstock</em></p>
<p><strong><em>Disclaimer</em>:</strong><em>&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</em></p>


Equities

FTAI

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HOOD

PHIG

PYPL

SMCI

SOFI

TMUS

Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Procter &amp; Gamble</strong>.</p>
<p>Looking at options history for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) we detected 24 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 54% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $252,750 and 22, calls, for a total amount of $3,417,975.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $160.0 to $185.0 for Procter &amp; Gamble over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Procter &amp; Gamble's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Procter &amp; Gamble's substantial trades, within a strike price spectrum from $160.0 to $185.0 over the preceding 30 days.</p>
<h3>Procter &amp; Gamble Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741032947_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.9</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$180.00</td>
<td>$1.8M</td>
<td>11.0K</td>
<td>5.0K</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$0.85</td>
<td>$0.81</td>
<td>$0.81</td>
<td>$180.00</td>
<td>$231.8K</td>
<td>5.4K</td>
<td>6.4K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$5.15</td>
<td>$4.95</td>
<td>$5.05</td>
<td>$160.00</td>
<td>$227.2K</td>
<td>1.6K</td>
<td>456</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$11.05</td>
<td>$10.45</td>
<td>$10.45</td>
<td>$180.00</td>
<td>$191.4K</td>
<td>5.0K</td>
<td>191</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.87</td>
<td>$0.83</td>
<td>$0.83</td>
<td>$180.00</td>
<td>$118.6K</td>
<td>5.4K</td>
<td>8.6K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<p>Following our analysis of the options activities associated with Procter &amp; Gamble, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Procter &amp; Gamble Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 4,222,841, the PG's price is up by 0.8%, now at $175.24. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 49 days.</li>
</ul>
<h3>What Analysts Are Saying About Procter &amp; Gamble</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $172.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Procter &amp; Gamble, targeting a price of $172. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter &amp; Gamble options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Procter & Gamble Unusual Options Activity

<p>12 analysts have shared their evaluations of Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $176.67, a high estimate of $209.00, and a low estimate of $155.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.35%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1740423636_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Procter &amp; Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$172.00</td>
<td>$173.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$164.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$165.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$159.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$209.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$155.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$161.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$189.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$181.00</td>
<td>$186.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$176.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$209.00</td>
<td>$209.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Procter &amp; Gamble. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Procter &amp; Gamble compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Procter &amp; Gamble's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Procter &amp; Gamble's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Procter &amp; Gamble analyst ratings.</strong></a></p>
<h2>Discovering Procter &amp; Gamble: A Closer Look</h2>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, with annual sales approaching $85 billion. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<h3>Procter &amp; Gamble's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Procter &amp; Gamble showcased positive performance, achieving a revenue growth rate of <strong>2.06%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Procter &amp; Gamble's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>20.83%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Procter &amp; Gamble's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>8.99%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Procter &amp; Gamble's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>3.66%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Procter &amp; Gamble's debt-to-equity ratio is below the industry average. With a ratio of <b>0.69</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Demystifying Procter & Gamble: Insights From 12 Analyst Reviews

<p>Piper Sandler  analyst Korinne Wolfmeyer   maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Neutral and lowers the price target from $173 to $172.</p>


Comments

Procter & Gamble

Noticias

Últimas noticias sobre Procter & Gamble (NYSE:PG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL